New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
Top Cited Papers
Open Access
- 26 March 2009
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 113 (13), 2895-2901
- https://doi.org/10.1182/blood-2008-07-170449
Abstract
Therapeutic decision-making in primary myelofibrosis (PMF) is becoming more challenging because of the increasing use of allogeneic stem cell transplaKeywords
This publication has 53 references indexed in Scilit:
- Hematopoietic Cell Transplantation as Curative Therapy for Idiopathic Myelofibrosis, Advanced Polycythemia Vera, and Essential ThrombocythemiaTransplantation and Cellular Therapy, 2007
- MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid MetaplasiaPLoS Medicine, 2006
- Regression models for relative survivalStatistics in Medicine, 2003
- Myelofibrosis with myeloid metaplasia in young indidviduals: disease characteristics, prognostic factors and identification of risk groupsBritish Journal of Haematology, 1998
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994
- Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study GroupBritish Journal of Haematology, 1994
- Primary myelofibrosis: A detailed statistical analysis of the clinicopathological variables influencing survivalAnnals of Hematology, 1994
- The Syndrome of Idiopathic MyelofibrosisMedicine, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958